The Second Annual LDN Conference (2006)
Updated: Mar 9, 2008
Other LDN Conference Reports & Multimedia
The Future is Now
The Second Annual LDN Conference
April 7, 2006 — National Library of Medicine
Post-Conference Report & Multimedia
2006 Post-Conference Report
The Second Annual Low Dose Naltrexone (LDN) Conference was held on Friday, April 7th, 2006 in the Lister Hill Center Auditorium of the National Library of Medicine at the National Institutes of Health in Bethesda, Maryland. The conference theme, "The Future Is Now," was selected because it reflects the amazing strides that have been made in LDN research and clinical trials since our last gathering.
During the course of the day, the attendees, who came from the far corners of the United States as well as from Europe, were treated to a series of expert presentations from a number of researchers, physicians, and LDN advocates.
The conference demonstrated that low dose naltrexone is a viable and potent form of therapy for a wide range of diseases. In addition, conference presenters described a number of new applications for LDN, including the remarkable power of the drug in treating childhood autism, and its potential in dealing with gynecological issues such as pre-menstrual symptoms, endometriosis, and polycystic ovaries.
Credit for the success of the conference goes to Susan Sedlock, who volunteered as the organizer and coordinator of the conference proceedings. In addition, many thanks are due to Dr. Skip Lenz, his wife Cyndi, and his son Adam, who graciously provided audio/visual support and other printing services for the conference.
Ms. Sedlock chose to designate the Second Annual Low Dose Naltrexone Conference as a fund raiser for THE LDN FOR MS RESEARCH FUND, and has contributed all registration fees to that cause. We continue to encourage all of our readers to support the Fund if at all possible—click here for donation information.
2006 Conference Multimedia
- Video clips below are in QuickTime format. If you have any difficulty in viewing a clip, please download the latest version of Quicktime. If you cannot view the video within your browser, try running QuickTime itself and using the "File | Open URL..." command (you will need to copy the video link from this page and paste it into QuickTime's Open URL dialogue box). Longer videos are stored in streaming format for faster loading. Please be patient as each video takes time to download.
- A Photo Gallery of the 2006 conference can be found here.
- NEW! View the 2006 conference trailer...
- Susan Sedlock, the organizer and coordinator for the 2006 conference,
greeted the attendees and emphasized the great improvement that LDN had
provided for her father for the several years after he was diagnosed with
multiple myeloma in his late 80's.
- Dr. David Gluck, editor of the website www.ldninfo.org and one of the
organizers of last year's conference, discussed "The Year in LDN." He
highlighted major contributions since June 2005 to strengthening the
belief in LDN's efficacy and in its probable mode of action. In the latter
half of his talk, he read remarkable messages from two people with
multiple sclerosis and one person with amyotrophic lateral sclerosis, all
of whom were struck with the obvious benefits of their LDN treatment.
- The Keynote Speaker, Dr. Jill Smith, Professor of Gastroenterology at the Hershey Medical Center (Pennsylvania State University), described her two breakthrough trials that demonstrated the successful use of LDN both in Crohn's disease in humans as well as in induced inflammatory bowel disease in mice.
Dr. Smith's studies, to be published in a major gastroenterology journal, represent the first reported human research on LDN at an American medical center. Dr. Smith presented the detailed results at Digestive Disease Week in May 2006 in Los Angeles. This meeting attracts more than 20,000 gastroenterologists and is the largest such in the world.
For further details on the Penn State studies, see the Clinical Trials for LDN page, and Penn State's online news.
- Dr. Jaquelyn McCandless, a Board-certified specialist in Psychiatry and Neurology, took up the cause of childhood autism 10 years ago when her granddaughter was diagnosed with that disorder. Dr. McCandless delivered a detailed discourse on the suspected causes of autism spectrum disorders and highlighted the role of LDN, which has impressed some 75% of affected parents as contributing to significant improvements in cognition and socialization in their children.
She also announced a current clinical study using LDN in autism involving 30 children and 70 adults, which will measure a panel of immune markers both before and after the sixteen weeks of the research, ending in June 2006.
Dr. McCandless said that, with LDN and other new treatment approaches, if she were given an autistic child by the age of three, she has grown much more optimistic about the child's being able to attend a mainstreamed kindergarten. Dr. McCandless is the author of the book Children With Starving Brains, and has written an article summarizing her work in using LDN to treat autism.
- William Way spoke as one of five participants on the LDN Advocates Panel. He described having first tested positive for HIV 16 years ago—since that time he has used nothing stronger than nightly LDN to treat the HIV infection. During these many years he reports that his CD4 cell count has, for the most part, remained in a favorable zone, and he has been symptom free. In contrast to virtually any other person who has carried an HIV infection for many years, Mr. Way has never had to use antiretroviral drugs, thus avoiding the attendant expense, annoying schedules, and risk of side-effects. Mr. Way's entire talk can be viewed here.
The LDN Advocates Panel featured presentations by Ann Brasher, Brenda Powell (whose words were read by Joel Gluck), William Way, Susan Sedlock, and Mary Boyle Bradley.
- Dr. Phil Boyle, a specialist in fertility care in Galway, presented a talk entitled "LDN in Clinical Practice—a Family Physician's Experience from Ireland." Dr. Boyle's presentation provided a compelling window into his journey from being an LDN skeptic to achieving unambiguous results with the drug in his own clinical practice. He spoke with honesty and humor of his experiences with both physician specialists (most of whom refused to put his findings into practice) and a wide range of patients troubled with rheumatoid arthritis, MS, gynecologic issues, and other disorders.
Following the work of Dr. Thomas Hilgers of Omaha, Nebraska, who has used naltrexone since 1990 in the treatment of infertility, Dr. Boyle has begun to see the application of LDN in his own infertility practice for patients who appear to have an underlying problem with inadequate endorphins. He suggests that issues such as endometriosis, polycystic ovarian disease, and premenstrual disorders may all respond favorably to LDN. Dr. Boyle has written a patient information leaflet on the use of LDN for abnormal gynecologic health.
- Dr. Skip Lenz presented his survey of 255 new patients who
received prescriptions for LDN. This was done to determine the incidence
of side effects among those who had discontinued its use (80) and those
still taking it (175). Of the 255 patients surveyed, only 13% experienced side effects while taking LDN.
Half of the side effects were mild, temporary sleep disturbances;
one-fourth of the side effects reported were related to muscle stiffness.
- Dr. Pat Crowley is currently working in County Kilkenny, Ireland in a
two-man family practice. He participated in making a half-hour documentary film about LDN that features an extensive interview with Dr. Bernard
Bihari and comments from two of Dr. Crowley's patients with MS.
- Additional Conference Multimedia: